Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,740 | 7 | 77.8% |
| Food and Beverage | $3,467 | 197 | 21.2% |
| Travel and Lodging | $175.00 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $13,485 | 35 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,088 | 72 | $0 (2024) |
| ABBVIE INC. | $280.57 | 16 | $0 (2024) |
| Amgen Inc. | $193.61 | 10 | $0 (2024) |
| LIFESCAN, INC. | $118.99 | 7 | $0 (2023) |
| Abbott Laboratories | $95.21 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $90.12 | 6 | $0 (2023) |
| Corcept Therapeutics | $79.99 | 4 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $75.27 | 4 | $0 (2024) |
| Dexcom, Inc. | $72.25 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.87 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($159.31) |
| 2023 | $341.86 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($61.82) |
| 2022 | $337.66 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($76.70) |
| 2021 | $311.59 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($118.09) |
| 2020 | $308.18 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($156.55) |
| 2019 | $621.93 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($260.00) |
| 2018 | $6,076 | 40 | Merck Sharp & Dohme Corporation ($5,672) |
| 2017 | $8,080 | 48 | Merck Sharp & Dohme Corporation ($7,795) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: DIABETES | ||||||
| 05/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: DIABETES | ||||||
| 03/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: DIABETES | ||||||
| 02/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: DIABETES | ||||||
| 12/07/2023 | Embecta Corp. | BD Nano 2nd Gen Pen Needle (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes Care | ||||||
| 12/04/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 10/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.40 | General |
| 10/04/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/20/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Endocrinology | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 08/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.63 | General |
| 08/14/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/31/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/05/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,349 | 6,754 | $990,660 | $361,043 |
| 2022 | 19 | 3,008 | 11,650 | $1.1M | $416,886 |
| 2021 | 22 | 3,346 | 11,981 | $1.2M | $463,000 |
| 2020 | 21 | 3,656 | 9,763 | $928,593 | $345,059 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 974 | 3,023 | $799,349 | $285,997 | 35.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 29 | 1,740 | $80,228 | $30,673 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 187 | 187 | $64,922 | $22,951 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 311 | 474 | $8,091 | $3,966 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 105 | 160 | $5,376 | $2,634 | 49.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 104 | 153 | $5,184 | $2,540 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 127 | 202 | $4,266 | $2,091 | 49.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 88 | 148 | $3,963 | $1,942 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 24 | $4,485 | $1,641 | 36.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 106 | 159 | $2,868 | $1,406 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 144 | $2,796 | $1,371 | 49.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 32 | 40 | $2,853 | $1,071 | 37.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 30 | 35 | $2,072 | $1,015 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 69 | $2,057 | $693.39 | 33.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 57 | 98 | $1,133 | $554.68 | 49.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 57 | 98 | $1,015 | $497.84 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 966 | 2,473 | $659,813 | $239,165 | 36.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 77 | 6,540 | $283,247 | $111,952 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 148 | 168 | $63,643 | $17,130 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $30,760 | $11,329 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 71 | 71 | $33,208 | $9,594 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 82 | $15,593 | $5,065 | 32.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 165 | 226 | $7,594 | $3,763 | 49.6% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2022 | 152 | 212 | $7,183 | $3,561 | 49.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 211 | 298 | $6,294 | $3,106 | 49.3% |
About Dr. Athanassios Drimoussis, M.D
Dr. Athanassios Drimoussis, M.D is a Internal Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346241254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Athanassios Drimoussis, M.D has received a total of $16,382 in payments from pharmaceutical and medical device companies, with $304.87 received in 2024. These payments were reported across 211 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,740).
As a Medicare-enrolled provider, Drimoussis has provided services to 12,359 Medicare beneficiaries, totaling 40,148 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Fort Myers, FL
- Active Since 08/02/2005
- Last Updated 03/08/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346241254
Products in Payments
- JANUMET (Drug) $9,505
- JANUVIA (Drug) $3,980
- JARDIANCE (Drug) $1,026
- Synthroid (Drug) $186.77
- EVENITY (Biological) $92.53
- FARXIGA (Drug) $90.12
- Korlym (Drug) $79.99
- SYNTHROID (Drug) $62.53
- Vascepa (Drug) $61.21
- Dexcom G6 Transmitter (Medical Supply) $60.14
- UNITHROID (Drug) $57.73
- NOCDURNA (Drug) $55.35
- Omnipod (Device) $53.63
- GVOKE PFS (Drug) $51.30
- FREESTYLE LIBRE 2 (Device) $47.59
- OneTouch Verio Reflect (Device) $42.90
- AFREZZA (Drug) $42.47
- BD Nano 2nd Gen Pen Needle (Device) $40.53
- Qutenza (Drug) $35.45
- SOLIQUA (Drug) $34.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Myers
Dr. Michael Oleksyk, Md, MD
Internal Medicine — Payments: $570,596
Dr. Malissa Wood, Md, MD
Internal Medicine — Payments: $377,298
Oliver Abela, Md, MD
Internal Medicine — Payments: $70,958
Francisco De Jesus Paulino, Md, MD
Internal Medicine — Payments: $50,407
Dr. Vinayak Thakur, M.d, M.D
Internal Medicine — Payments: $19,038
Imtiaz Ahmad, Md, MD
Internal Medicine — Payments: $18,331